This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Health maintenance organization
United States Preventive Services Task Force
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016;315:2564-2575.
White A., Thompson T.D., White M.C., et al: Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 2017; 66: pp. 201-206.
Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study. Ann Intern Med 2016;164:456-63.
Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D. The effect of area HMO market share on cancer screening. Health Serv Res 2004;39:1751–72.
Shariff-Marco S, Breen N, Stinchcomb DG, Klabunde CN. Multilevel predictors of colorectal cancer screening use in California. Am J Manag Care 2013;19(3):205–216.
Subramanian S, Tangka FKL, Hoover S, et al. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening. Eval Program Plann 2017;62:73-80.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bushyhead, D., Fishman, P. Managed Health Care and Utilization of Fecal Occult Blood Testing for Colorectal Cancer Screening: a National Database Study. J GEN INTERN MED 35, 357–359 (2020). https://doi.org/10.1007/s11606-019-05504-7